miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Nasopharyngeal carcinoma (NPC) is a prevalent head and neck cancer.
• The role and mechanism of microRNA-4792 (miR-4792) in NPC remain largely unelucidated.
• Epithelial-mesenchymal transition (EMT) and invasion are critical processes in NPC progression.

Purpose of the Study:

• To investigate the function and mechanism of miR-4792 in NPC.
• To determine the relationship between miR-4792 and NPC cell EMT and invasion.
• To identify potential therapeutic targets for NPC treatment.

Main Methods:

• Analysis of published microarray data.
• In vitro cell-based assays to assess EMT and invasion.
• Identification and validation of direct miR-4792 targets using 3'UTR assays.
• In vivo animal experiments to evaluate anti-tumor effects.

Main Results:

• miR-4792 expression was significantly downregulated in NPC tissues.
• Inverse correlation observed between miR-4792 levels and NPC cell EMT/invasion.
• Upregulation of miR-4792 suppressed NPC cell EMT and invasion.
• FOXC1 was identified as a direct target of miR-4792.
• Overexpression of miR-4792 inhibited NPC tumor growth in vivo.

Conclusions:

• miR-4792 functions as a tumor suppressor in NPC.
• miR-4792 inhibits NPC progression by targeting FOXC1 and regulating EMT.
• The miR-4792/FOXC1 pathway represents a potential therapeutic strategy for NPC.